BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cataldi M, Muscogiuri G, Savastano S, Barrea L, Guida B, Taglialatela M, Colao A. Gender-related issues in the pharmacology of new anti-obesity drugs. Obes Rev 2019;20:375-84. [PMID: 30589980 DOI: 10.1111/obr.12805] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Mauvais-Jarvis F, Berthold HK, Campesi I, Carrero JJ, Dakal S, Franconi F, Gouni-Berthold I, Heiman ML, Kautzky-Willer A, Klein SL, Murphy A, Regitz-Zagrosek V, Reue K, Rubin JB. Sex- and Gender-Based Pharmacological Response to Drugs. Pharmacol Rev 2021;73:730-62. [PMID: 33653873 DOI: 10.1124/pharmrev.120.000206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
2 Moreira-Pais A, Ferreira R, Neves JS, Vitorino R, Moreira-Gonçalves D, Nogueira-Ferreira R. Sex differences on adipose tissue remodeling: from molecular mechanisms to therapeutic interventions. J Mol Med (Berl) 2020;98:483-93. [PMID: 32152705 DOI: 10.1007/s00109-020-01890-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
3 Castellucci B, Barrea L, Laudisio D, Aprano S, Pugliese G, Savastano S, Colao A, Muscogiuri G. Improving sleep disturbances in obesity by nutritional strategies: review of current evidence and practical guide. Int J Food Sci Nutr 2021;72:579-91. [PMID: 33238797 DOI: 10.1080/09637486.2020.1851659] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Luetić M, Kretzschmar G, Grobe M, Jerčić L, Bota I, Ivić V, Balog M, Zjalić M, Vitlov Uljević M, Heffer M, Gaspar R, Tabi T, Vukojević K, Vari SG, Filipović N. Sex-specific effects of metformin and liraglutide on renal pathology and expression of connexin 45 and pannexin 1 following long-term high-fat high-sugar diet. Acta Histochem 2021;123:151817. [PMID: 34808525 DOI: 10.1016/j.acthis.2021.151817] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fu M, Bao T, Yu H, A. L, Li H, Ba G, Cho S. Metabolomics investigation on antiobesity effects of Corydalis bungeana on high-fat high-sugar diet-induced obese rats. Chinese Herbal Medicines 2022. [DOI: 10.1016/j.chmed.2022.04.001] [Reference Citation Analysis]
6 Kapoor N, Arora S, Kalra S. Gender Disparities in People Living with Obesity - An Unchartered Territory. J Midlife Health 2021;12:103-7. [PMID: 34526743 DOI: 10.4103/jmh.jmh_48_21] [Reference Citation Analysis]
7 Cataldi M, Cignarelli A, Giallauria F, Muscogiuri G, Barrea L, Savastano S, Colao A; Obesity Programs of nutrition, Education, Research and Assessment (OPERA) Group. Cardiovascular effects of antiobesity drugs: are the new medicines all the same? Int J Obes Suppl 2020;10:14-26. [PMID: 32714509 DOI: 10.1038/s41367-020-0015-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Barrea L, Frias-Toral E, Pugliese G, Garcia-Velasquez E, DE Los Angeles Carignano M, Savastano S, Colao A, Muscogiuri G. Vitamin D in obesity and obesity-related diseases: an overview. Minerva Endocrinol (Torino) 2021;46:177-92. [PMID: 33213116 DOI: 10.23736/S2724-6507.20.03299-X] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
9 Lautenbach A, Wernecke M, Huber TB, Stoll F, Wagner J, Meyhöfer SM, Meyhöfer S, Aberle J. The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis. Obes Surg 2022. [PMID: 35879524 DOI: 10.1007/s11695-022-06211-9] [Reference Citation Analysis]
10 Liu J, Zhu Y, He Y, Zhu H, Gao Y, Li Z, Zhu J, Sun X, Fang F, Wen H, Li W. Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing. J Biomol Struct Dyn 2020;38:533-47. [PMID: 30938574 DOI: 10.1080/07391102.2019.1590241] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
11 Nishiya Y, Daimon M, Mizushiri S, Murakami H, Tanabe J, Matsuhashi Y, Yanagimachi M, Tokuda I, Sawada K, Ihara K. Nutrient consumption-dependent association of a glucagon-like peptide-1 receptor gene polymorphism with insulin secretion. Sci Rep 2020;10:16382. [PMID: 33009421 DOI: 10.1038/s41598-020-71853-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Choe MK, Kim HJ, Kim NH, Binas B, Kim HJ. Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice. Pharmaceuticals (Basel) 2021;14:330. [PMID: 33916621 DOI: 10.3390/ph14040330] [Reference Citation Analysis]
13 Moyer AM, Matey ET, Miller VM. Individualized medicine: Sex, hormones, genetics, and adverse drug reactions. Pharmacol Res Perspect 2019;7:e00541. [PMID: 31844524 DOI: 10.1002/prp2.541] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
14 Mishra I, Xie WR, Bournat JC, He Y, Wang C, Silva ES, Liu H, Ku Z, Chen Y, Erokwu BO, Jia P, Zhao Z, An Z, Flask CA, He Y, Xu Y, Chopra AR. Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor. Cell Metab 2022:S1550-4131(22)00084-5. [PMID: 35298903 DOI: 10.1016/j.cmet.2022.02.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Cooper AJ, Gupta SR, Moustafa AF, Chao AM. Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment. Curr Obes Rep 2021. [PMID: 34599745 DOI: 10.1007/s13679-021-00453-x] [Reference Citation Analysis]
16 Gembillo G, Cernaro V, Giuffrida AE, Russo G, Giandalia A, Siligato R, Longhitano E, Santoro D. Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review. Expert Rev Clin Pharmacol 2022. [PMID: 35300556 DOI: 10.1080/17512433.2022.2055546] [Reference Citation Analysis]